Benzinga | May 13, 2021 07:14AM EDT

Anavex Life Sciences Q2 EPS $(0.12) Beats $(0.14) Estimate

Anavex Life Sciences (NASDAQ:AVXL) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) by 14.29 percent. This is unchanged from the same period last year.